Double-blind control trial of alpha electroencephalogramguided transcranial magnetic stimulation treatment for schizophrenia

Wan-jiao Xu,Yi Jin,Yue-qin Huang,Zhao-rui Liu,Hua He,Jin Chen

DOI: https://doi.org/10.3321/j.issn:1673-8225.2006.46.012

2006-01-01

Abstract:AIM: To observe and evaluate the clinical effect of alpha electroencephalogram (EEG) guided transcranial magnetic stimulation (αTMS) on the positive symptoms and negative symptoms of patients with schizophrenia and the effect in stimulating different sites. METHODS: Sixty-seven patients with schizophrenia were selected from the two special hospitals in psychiatry of third grade in first level between December 2004 and December 2005. According to the treatment and stimulating site, the patients were randomly divided into 4 groups. Besides, patients were divided into the treatment group and the control group (at the ratio of 2∶1), and these two groups were redivided into two groups according to the stimulating site [bilateral dorsolateral prefrontal cortex (DLPFC) and the bilateral parietal lobe]: frontal lobe (FL) treatment group, parietal lobe (PL) treatment group, FL control group and PL control group. Patients in the control group received placebo and double blind design. The stimulating frequency was set according to the basic frequency at EEG of each patient, and the intensity was 80% of the movement threshold value of each patient. α TMS was applied for 20 for minutes per day (each segment was stimulated for 4 s with an interval of 56 s for totally 20 segments), and the treatment was given 5 times a week for 2 continuous weeks. PANSS and clinical global impressions scale (CGI) were used for evaluation before and after the treatment. The reducing rate in PANSS score at 2 weeks after the treatment = [ln (PANSS score before the treatment) - ln (PANSS score at 2 weeks after the treatment)]/[ln (PANSS score before the treatment) - ln (7)]. The score of CGI included 7 grades: Zero as no evaluation; 1 as much significant progress; 2 as obvious progress; 3 as slight progress; 4 as no change; 5 as slight aggravation; 6 as significant aggravation; 7 as much significant aggravation. RESULTS: Of 67 patients, 63 patients accomplished 2-week treatment, while 4 patients withdrew from the experiment, including 3 patients in the FL treatment group and one patient in the PL treatment group. The positive symptoms in the treatment group after the treatment were significantly ameliorated than those in the control group, while there were no significant differences in negative symptom amelioration and the total score of Negative Symptom Scale between the two groups. ② The CGI score of the treatment groupa two weeks later approached to that of the control group, and the difference was not significant [(3.3±0.9),(3.6±0.7) points,t=-1.344,P=0.184]. ③ α TMS treatment at both frontal and parietal locations showed no difference in therapeutic effect. ④ No severe adverse effects were observed except one patient withdrew from the study due to the exacerbation of psychotic symptoms.CONCLUSION: The alpha EEG guided TMS can ameliorate the positive symptoms of patients with schizophrenia, which may be an effective treatment for schizophrenia, and it is characteristics of no wounds, safety and less side effects.